Insider Transactions Reported by 29 Insiders of Vera Therapeutics, Inc.

Symbol
VERA on Nasdaq
Location
Brisbane, CA

Insiders trading volume in the past year

Vera Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Patrick G. Enright Director $102,609,021 +$5,527,296 +5.7% 11 Dec 2025
Commodore Capital LP 10%+ Owner $79,200,000 10 Jan 2024
Sofinnova Venture Partners X, L.P. 10%+ Owner $62,408,808 06 Feb 2023
Emster Kurt von Director $53,605,062 17 May 2021
Abingworth LLP 10%+ Owner $53,284,158 13 May 2021
Carlyle Group Inc. 10%+ Owner $53,284,158 17 Aug 2022
Longitude Prime Partners, LLC 10%+ Owner $30,857,130 06 Feb 2023
Longitude Capital Partners IV, LLC 10%+ Owner $30,857,130 06 Feb 2023
Marshall Fordyce PRESIDENT AND CEO, Director $20,812,477 -$710,578 -3.3% 23 Feb 2026
Beth C. Seidenberg Director $6,715,972 14 May 2025
Sean Grant Chief Financial Officer $5,019,313 -$207,778 -4% 23 Feb 2026
Joseph R. Young Svp, Finance, Chief Acct Offcr $3,417,262 -$566,738 -14% 13 Mar 2026
Laurence Matthew Skelton Chief Commercial Officer $2,696,122 -$66,419 -2.4% 23 Feb 2026
Robert Brenner Chief Medical Officer $2,138,953 -$90,307 -4.1% 23 Feb 2026
David Lee Johnson Chief Operating Officer $1,919,797 -$108,276 -5.3% 23 Feb 2026
William D. Turner Chief Regulatory Officer $1,902,416 -$1,445,639 -43% 23 Feb 2026
Jason S. Carter Chief Legal Officer $1,366,983 -$107,498 -7.3% 21 Nov 2025
Joanne Curley Chief Development Officer $485,316 21 Aug 2023
Celia Lin Chief Medical Officer $198,180 21 Aug 2023
Christy J. Oliger Director $128,528 14 May 2025
Ares Trading S.A. 10%+ Owner 13 May 2021
James R. Meyers Director 25 Nov 2025
Michael Morrissey Director 14 May 2025
Maha Katabi Director 14 May 2025
Scott W. Morrison Director 14 May 2025
Christopher Hite Director 05 Mar 2026
Andrew Cheng Director 14 May 2025
Jonathan Wolter Chief Financial Officer 13 May 2021
Kimball Hall Director 14 May 2025

Recent Insider Transactions by Companies or Individuals for Vera Therapeutics, Inc.

Showing up to 300 most recent insider transactions from the last 12 months.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
Joseph R. Young VERA Class A Common Stock Options Exercise 15.2% 10,000 75,754 13 Mar 2026 Direct
Joseph R. Young VERA Stock Option (right to buy) Options Exercise -20.6% -10,000 38,589 13 Mar 2026 Direct
Christopher Hite VERA Stock Option (right to buy) Award 24,937 24,937 05 Mar 2026 Direct
Robert Brenner VERA Class A Common Stock Sale -4.05% $90,307 $41.98 -2,151 50,947 23 Feb 2026 Direct
Joseph R. Young VERA Class A Common Stock Sale -4.59% $130,864 $41.98 -3,117 64,722 23 Feb 2026 Direct
Sean Grant VERA Class A Common Stock Sale -4.15% $207,778 $41.98 -4,949 114,181 23 Feb 2026 Direct
Marshall Fordyce VERA Class A Common Stock Sale -6.18% $710,578 $41.98 -16,925 257,163 23 Feb 2026 Direct
David Lee Johnson VERA Class A Common Stock Sale -5.34% $108,276 $41.98 -2,579 45,727 23 Feb 2026 Direct
William D. Turner VERA Class A Common Stock Sale -4.6% $91,819 $41.98 -2,187 45,313 23 Feb 2026 Direct
Laurence Matthew Skelton VERA Class A Common Stock Sale -2.4% $66,419 $41.98 -1,582 64,218 23 Feb 2026 Direct
Joseph R. Young VERA Class A Common Stock Award 17.3% 10,000 67,839 04 Feb 2026 Direct
Joseph R. Young VERA Stock Option (right to buy) Award 20,000 20,000 04 Feb 2026 Direct
Marshall Fordyce VERA Class A Common Stock Award 33.5% 68,800 274,088 04 Feb 2026 Direct
Marshall Fordyce VERA Stock Option (right to buy) Award 137,500 137,500 04 Feb 2026 Direct
Sean Grant VERA Class A Common Stock Award 26.6% 25,000 119,130 04 Feb 2026 Direct
Sean Grant VERA Stock Option (right to buy) Award 50,000 50,000 04 Feb 2026 Direct
Laurence Matthew Skelton VERA Class A Common Stock Award 43.7% 20,000 65,800 04 Feb 2026 Direct
Laurence Matthew Skelton VERA Stock Option (right to buy) Award 40,000 40,000 04 Feb 2026 Direct
William D. Turner VERA Class A Common Stock Award 111.1% 25,000 47,500 04 Feb 2026 Direct
William D. Turner VERA Stock Option (right to buy) Award 50,000 50,000 04 Feb 2026 Direct
David Lee Johnson VERA Class A Common Stock Award 70.7% 20,000 48,306 04 Feb 2026 Direct
David Lee Johnson VERA Stock Option (right to buy) Award 40,000 40,000 04 Feb 2026 Direct
Robert Brenner VERA Class A Common Stock Award 89% 25,000 53,098 04 Feb 2026 Direct
Robert Brenner VERA Stock Option (right to buy) Award 50,000 50,000 04 Feb 2026 Direct
William D. Turner VERA Class A Common Stock Sale -30.8% $500,767 $50.08 -10,000 22,500 15 Dec 2025 Direct
William D. Turner VERA Class A Common Stock Options Exercise 44.4% 10,000 32,500 15 Dec 2025 Direct
William D. Turner VERA Stock Option (right to buy) Options Exercise -3.92% -10,000 245,000 15 Dec 2025 Direct
Patrick G. Enright VERA Class A Common Stock Purchase $249,985 $42.50 5,882 5,882 11 Dec 2025 Direct
William D. Turner VERA Class A Common Stock Sale -30.8% $453,053 $45.31 -10,000 22,500 08 Dec 2025 Direct
William D. Turner VERA Class A Common Stock Options Exercise 44.4% 10,000 32,500 08 Dec 2025 Direct
William D. Turner VERA Stock Option (right to buy) Options Exercise -3.77% -10,000 255,000 08 Dec 2025 Direct
William D. Turner VERA Class A Common Stock Sale -30.8% $400,000 $40.00 -10,000 22,500 03 Dec 2025 Direct
William D. Turner VERA Class A Common Stock Options Exercise 44.4% 10,000 32,500 03 Dec 2025 Direct
William D. Turner VERA Stock Option (right to buy) Options Exercise -3.64% -10,000 265,000 03 Dec 2025 Direct
James R. Meyers VERA Stock Option (right to buy) Award 25,000 25,000 25 Nov 2025 Direct
Jason S. Carter VERA Class A Common Stock Sale -7.29% $107,498 $27.82 -3,864 49,136 21 Nov 2025 Direct
Joseph R. Young VERA Class A Common Stock Options Exercise 20.9% 10,000 57,839 13 Nov 2025 Direct
Joseph R. Young VERA Stock Option (right to buy) Options Exercise -17.1% -10,000 48,589 13 Nov 2025 Direct
Joseph R. Young VERA Class A Common Stock Sale -23.9% $435,874 $29.06 -15,000 47,839 11 Nov 2025 Direct
Patrick G. Enright VERA Class A Common Stock Purchase 1.14% $907,635 $22.35 40,607 3,596,593 24 Jun 2025 See footnote
Patrick G. Enright VERA Class A Common Stock Purchase 6.23% $4,369,676 $20.87 209,393 3,569,522 23 Jun 2025 See footnote
Maha Katabi VERA Stock Option (right to buy) Award 14,000 14,000 14 May 2025 Direct
Patrick G. Enright VERA Stock Option (right to buy) Award 14,000 14,000 14 May 2025 Direct
Christy J. Oliger VERA Stock Option (right to buy) Award 14,000 14,000 14 May 2025 Direct
Michael Morrissey VERA Stock Option (right to buy) Award 14,000 14,000 14 May 2025 Direct
Beth C. Seidenberg VERA Stock Option (right to buy) Award 14,000 14,000 14 May 2025 Direct
Kimball Hall VERA Stock Option (right to buy) Award 14,000 14,000 14 May 2025 Direct
Scott W. Morrison VERA Stock Option (right to buy) Award 14,000 14,000 14 May 2025 Direct
Andrew Cheng VERA Stock Option (right to buy) Award 14,000 14,000 14 May 2025 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.